JP2024534442A5 - - Google Patents
Info
- Publication number
- JP2024534442A5 JP2024534442A5 JP2024516893A JP2024516893A JP2024534442A5 JP 2024534442 A5 JP2024534442 A5 JP 2024534442A5 JP 2024516893 A JP2024516893 A JP 2024516893A JP 2024516893 A JP2024516893 A JP 2024516893A JP 2024534442 A5 JP2024534442 A5 JP 2024534442A5
- Authority
- JP
- Japan
- Prior art keywords
- expression system
- optionally
- based expression
- chadv
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163245663P | 2021-09-17 | 2021-09-17 | |
| US63/245,663 | 2021-09-17 | ||
| US202163281027P | 2021-11-18 | 2021-11-18 | |
| US63/281,027 | 2021-11-18 | ||
| US202263320685P | 2022-03-16 | 2022-03-16 | |
| US63/320,685 | 2022-03-16 | ||
| PCT/US2022/076678 WO2023044492A2 (en) | 2021-09-17 | 2022-09-19 | Neoantigen adjuvant and maintenance therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534442A JP2024534442A (ja) | 2024-09-20 |
| JP2024534442A5 true JP2024534442A5 (https=) | 2025-09-29 |
Family
ID=85603658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516893A Pending JP2024534442A (ja) | 2021-09-17 | 2022-09-19 | ネオ抗原アジュバント及び維持療法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240216501A1 (https=) |
| EP (1) | EP4401765A4 (https=) |
| JP (1) | JP2024534442A (https=) |
| KR (1) | KR20240099144A (https=) |
| AU (1) | AU2022347452A1 (https=) |
| CA (1) | CA3231295A1 (https=) |
| IL (1) | IL311252A (https=) |
| WO (1) | WO2023044492A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025207975A1 (en) * | 2024-03-27 | 2025-10-02 | Seattle Project Corp. | Personalized cancer vaccines and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3743102A1 (en) * | 2018-01-26 | 2020-12-02 | Nantcell, Inc. | Compositions and methods for combination cancer vaccine and immunologic adjuvant therapy |
| WO2021092095A1 (en) * | 2019-11-04 | 2021-05-14 | Gritstone Oncology, Inc. | Neoantigen vaccine therapy |
| WO2021119545A1 (en) * | 2019-12-11 | 2021-06-17 | Gritstone Bio, Inc. | Durable vaccination |
-
2022
- 2022-09-19 CA CA3231295A patent/CA3231295A1/en active Pending
- 2022-09-19 JP JP2024516893A patent/JP2024534442A/ja active Pending
- 2022-09-19 AU AU2022347452A patent/AU2022347452A1/en active Pending
- 2022-09-19 IL IL311252A patent/IL311252A/en unknown
- 2022-09-19 EP EP22871018.2A patent/EP4401765A4/en active Pending
- 2022-09-19 KR KR1020247010182A patent/KR20240099144A/ko active Pending
- 2022-09-19 WO PCT/US2022/076678 patent/WO2023044492A2/en not_active Ceased
-
2024
- 2024-03-15 US US18/607,027 patent/US20240216501A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022512912A5 (https=) | ||
| CN112912507A (zh) | 甲病毒新抗原载体和干扰素抑制剂 | |
| IL260030B2 (en) | Therapeutic anticancer neoepitope vaccine | |
| JP2024535855A5 (https=) | ||
| JP2023523414A5 (https=) | ||
| JP7384896B2 (ja) | 主要組織適合遺伝子複合（ｍｈｃ）クラスｉｉ－発現癌細胞ワクチン、及び統合免疫応答を生じさせるための使用方法 | |
| JP2025148481A (ja) | マルチドメインタンパク質ワクチン | |
| CN115003322A (zh) | 癌症疫苗 | |
| JP2021532122A (ja) | 癌のための個別化ワクチン | |
| JP2021525549A5 (https=) | ||
| JP2024535855A (ja) | Ｋｒａｓネオ抗原療法 | |
| JP2024534442A5 (https=) | ||
| Wang et al. | Current status and progress of the development of prostate cancer vaccines | |
| JP2023512654A5 (https=) | ||
| JP7585480B2 (ja) | Ｐｄ－ｌ１の細胞外ドメインを含むキメラ抗原 | |
| Galant et al. | mRNA vaccines in the treatment of cancer | |
| US20240216501A1 (en) | Neoantigen adjuvant and maintenance therapy | |
| Ibragimova et al. | mRNA-based personalized cancer vaccines: opportunities, challenges and outcomes | |
| Lv et al. | Neoantigen immunotherapy: a novel treatment for bladder cancer | |
| CA3133972A1 (en) | Methods for inducing an immune response against neoantigens | |
| CN110996991A (zh) | haNK西妥昔单抗组合和方法 | |
| CN120590547B (zh) | 通用型mRNA肿瘤疫苗及其制备方法和用途 | |
| US20220370581A1 (en) | Vaccine and method for treating cancer | |
| Hassanel et al. | Oncofetal reprogramming in hepatocellular carcinoma: linking developmental programs to cancer vaccines and immunotherapy | |
| TW202440154A (zh) | 用ｐｄ－１軸結合拮抗劑及ｒｎａ疫苗治療胰臟癌之方法 |